Stay updated on Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T14:16:48.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added revision label v3.5.0 and removed revision label v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T20:15:35.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This is a non-functional update that does not change study content or user interactions.
    Difference
    0.0%
    Check dated 2026-03-07T13:10:43.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added Principal Investigator Julie Specht, MD and updated the recruiting contact at The Christ Hospital Cancer Center. Expanded the study locations to 15 sites, including Cincinnati, Ohio.
    Difference
    0.6%
    Check dated 2026-02-28T06:54:51.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T18:01:34.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    A minor revision update from v3.4.0 to v3.4.1 is displayed across the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:22:43.000Z thumbnail image

Stay in the know with updates to Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page.